SIU 2020 Abstract Listing Last Updated: October 09, 2020 Standard ePoster Adrenals SP-01.01 A 16 Year Review of Management of Incidental Adrenal Masses: Should We Remove Based on Size Alone? Melissa Gabriel, United Kingdom SP-01.02 Laparoscopic Adrenalectomy for Malignant Tumors: A Retrospective Analysis of Kyushu University Hospital Keisuke Monji, Japan SP-01.03 Laparoscopic Adrenalectomy: Outcomes of Enhanced Recovery Pathways at our Regional Cancer Centre Flora Langman, United Kingdom Basic Science - Benign Diseases SP-02.01 Comparative Analysis of Gut Microbiome Composition Between Men with Peyronie’s Disease and a Matched Cohort: Is there a Difference? Mohamad Osman, United States SP-02.02 Congenital Malformations of the Genito-Urinary Tract Associated to Isodicentric Yq Chromosome Nouha Bouayed Abdelmoula, Tunisia SP-02.03 Establishment of Infectious Stone in Rats Yang Hong, China SP-02.04 Knockout of Phosphatidylethanolamine Binding Protein 4 (PEBP4) Induces Prostatovesiculitis via NF-κB Signaling Xiaofeng Zou, China All SIU 2020 abstracts may be viewed via SIU Academy. 1/56 SIU 2020 Abstract Listing Last Updated: October 09, 2020 SP-02.05 Nerve Growth Factor Precursor (proNGF) Exerts Different Biological Actions on Urothelial and Smooth Muscle Cells of Rodents Bladders Abubakr Mossa, Canada SP-02.06 Renal Denervation Alleviate Renal Ischemic Reperfusion Injury Induced Acute and Chronic Kidney Injury Partly by Modulating miRNAs in Rats Jie Sun, China Bladder Cancer SP-03.01 ADNP Prompts the Progression of Bladder Cancer via Transforming Growth Factor (TGF)-β-Mediated Epithelial-Mesenchymal Transition (EMT) Pathway Yu Xie, China SP-03.02 Effect of Low Energy Shock Wave Therapy on Intravesical Epirubicin Delivery in a Rat Model of Bladder Cancer Ahmed Elkashef, Egypt SP-03.03 Global BCG Shortage Affects Bladder Cancer Treatment Michael Harvey, Australia SP-03.04 Investigating the Association between the Urinary Microbiome and Bladder Cancer: An Exploratory Study Umar Iqbal, United States SP-03.05 Molecular Visualization of Orthotopic Bladder Tumors in Dogs Under Confocal Laser Endomicroscopy Zhenduo Shi, China SP-03.06 Multimodal Fiber Optic Spectroscopy for Detecting Tumor Grade and Stage in Urothelial Cancer Diagnosis. Current Results Simone Morselli, Italy SP-03.07 Observation of Curative Effect of Transurethral Thulium Laser Stratified Resection for Non-Muscle Invasive Bladder Tumor Xiaofeng Zou, China All SIU 2020 abstracts may be viewed via SIU Academy. 2/56 SIU 2020 Abstract Listing Last Updated: October 09, 2020 SP-03.08 Optimizing Sequence of Therapy and Radiation Delivery When Combined with PD-L1 Immune- Checkpoint Inhibition in Bladder Cancer Côme Tholomier, Canada SP-03.09 Preparation of Bitter Gourd Ribosomal Inactivating Protein MAP30 and the Study of Inhibition on Bladder Urothelial Carcinoma Zhenduo Shi, China SP-03.10 Review of Bacillus Calmette-Guerin (BCG) Tolerability and Complications of Intravesical Therapy for Non- Muscle Invasive Bladder Cancer (NMIBC) Over a 4 Year Period Venetia Hoe, Australia SP-03.11 The FOXA1-KDM6A-ARHGDIB Axis Suppresses Cell Migration and Invasion in Human Bladder Cancer Lei Liu, China SP-03.12 The Promising Diagnostic Accuracy of Methylation Genes in Urine for the Detection of Bladder Cancer Yu Xie, China SP-03.13 The Role of Perpheric Inflammatory Markers in the Prognosis of Non-Muscle Invasive Bladder Cancer Roberto Martínez, Spain SP-03.14 “Two-Zone and Three-Segment” Laparoscopic Radical Cystectomy vs Conventional Laparoscopic Radical Cystectomy for Male Patients with Bladder Urothelial Carcinoma: A Retrospective Analysis Benkang Shi, China SP-03.15 Anaerobic Threshold Correlated to Length of Hospital Stay and Complication Rate for Radical Cystectomy Patients Mriganka Mani Sinha, United Kingdom SP-03.16 Assessing the Safety of Follow-Up After Induction BCG Using Urine Cytology and Flexible Cystoscopy Lisa Bibby, United Kingdom SP-03.17 Comparing Costs of Radical Versus Partial Cystectomy for Patients Diagnosed with Localized Muscle- Invasive Bladder Cancer: Understanding the Value of Surgical Care Aditya Srinivasan, United States All SIU 2020 abstracts may be viewed via SIU Academy. 3/56 SIU 2020 Abstract Listing Last Updated: October 09, 2020 SP-03.18 Comparison Between Primary and Secondary Muscle-Invasive Bladder Cancer Based on a Chinese Cohort from West China Hospital Xiaonan Zheng, China SP-03.19 Comparison Low Pressure to Standard Pressure Robotic Assisted Radical Cystectomy: A Pilot study Vishwanath Hanchanale, United Kingdom SP-03.20 Comparison of Open Radical Cystectomy versus Robotic assisted Radical Cystectomy: Our experience at Tertiary Care Centre Avinash Ranganagouda Odugoudar, United Kingdom SP-03.21 Complete Urinary Tract Exenteration (CUTE) for Invasive Bladder Urothelial Carcinoma in ESRD Patient on Hemodialysis Magdy El-Bahnasawy, Saudi Arabia SP-03.22 Could Urinary-Based Molecular Markers Discriminate between Non-Muscle Invasive and Muscle Invasive Bladder Cancer? Ahmed Elkashef, Egypt SP-03.23 COVID-19 and Bladder Cancer: Are Social and Clinical Restrictions Presenting Barriers to Patients Requiring Transurethral Resection of Bladder Tumour (TURBT)? Dominic Bagguley, Australia SP-03.24 Diagnostic and Surveillance Cystoscopy for Bladder Cancer – Pushing Boundaries During COVID-19 Dominic Bagguley, Australia SP-03.25 Do Urinary-Based Molecular Biomarkers Have the Ability to Predict the Grade of Non-Muscle Invasive Bladder Cancer? Ahmed Elkashef, Egypt SP-03.26 Enhanced Recovery After Surgery for Robotic-Assisted Laparoscopic Radical Cystectomy: A Single-Center Experience Fu Ho Victor Cheung, Hong Kong SP-03.27 Geographic Distribution of Racial Differences in Bladder Cancer Mortality in the United States: A Nationwide Population-Based Study Ariza Martinez, United States All SIU 2020 abstracts may be viewed via SIU Academy. 4/56 SIU 2020 Abstract Listing Last Updated: October 09, 2020 SP-03.28 Immunotherapy in Advanced Urothelial Cancer: Initial Experience Lorena García García, Spain SP-03.29 Is Re-Resection TUR Always Needed in the Management of Patients with High-Risk Non-Muscle-Invasive Bladder Cancer (TaG3/T1 with or without CIS) Treated with Bacillus Calmette-Guerin? Kenneth Hiew, United Kingdom SP-03.30 Is There a Difference Between Intravesical Chemotherapy and Immunotherapy for the Non-Muscle Invasive Bladder Cancer in Real Practice?: A Prospective Multicenter Study Phil Hyun Song, South Korea SP-03.31 Multiparametric 3T MRI for Staging of Bladder Cancer: Radiologic and Histopathologic Comparison from a Single Australian Center Ting Yiu, Australia SP-03.32 Oncological Outcomes of Contemporary Series of Robot-Assisted versus Open Radical Cystectomy at 10 Years Follow up Muhammad Waqar, United Kingdom SP-03.33 Oncological, Sexual, and Urinary Outcomes of Organ-Sparing Cystectomy versus Standard Radical Cystectomy: A Systematic Review and Meta-Analysis Raghav Shaunak, United Kingdom SP-03.34 Osmotic Cytolytic Effects of Water on Cell Counts - Implication for Clinical Use of Water Irrigation to Reduce NMIBC Recurrence Ruchira Nandurkar, Australia SP-03.35 Outpatient Transurethral Laser Ablation for Urothelial Cancer – A Safe Alternative to TURBT in the Era of COVID-19 James Aljoe, United Kingdom SP-03.36 Perioperative and Oncologic Outcomes of Robot-Assisted Radical Cystectomy in North American versus European Institutes Utilizing the International Robotic Cystectomy Consortium Umar Iqbal, United States SP-03.37 All SIU 2020 abstracts may be viewed via SIU Academy. 5/56 SIU 2020 Abstract Listing Last Updated: October 09, 2020 Preliminary Study of the Safety of Ethacridine Lactate for Visualizing of Cancer Nuclei Using Probe-Based Confocal Laser Endomicroscopy During Transurethral Resection of Bladder Cancer Yoshio Naya, Japan SP-03.38 Prognostic Significance of Pre-Operative Neutrophil Lymphocyte Ratio (NLR) in Patients with Muscle Invasive Bladder Cancer: A Retrospective Analysis Ritesh Goel, India SP-03.39 Prostate Specific Membrane Antigen (PSMA) in Urothelial Cell Carcinoma (UCC): A Systematic Review of the Literature Arsalan Tariq, Australia SP-03.40 Proximity to Oil Refineries and Risk of Bladder Cancer: A Population-Based Analysis Aditya Srinivasan, United States SP-03.41 Radical Cystectomies – Too Many Doing Too Few Reflects in Length of Stay Nuno Dias, Portugal SP-03.42 Radical Cystectomy in Elderly Patients: Postoperative Complications and Oncological Outcomes Alberto del Cristo Artiles Medina, Spain SP-03.43 Relapse Rates, Patterns, and Survival After Robot-Assisted Radical: Results from the International Robotic Cystectomy Consortium Umar Iqbal, United States SP-03.44 Robotic Cystectomy Histopathology Outcomes in Patients Who Have ‘Failed’ BCG Edward Hart, United Kingdom SP-03.45 Role of the Preoperative Magnetic Resonance Imaging in Classifying Non-Muscle and Muscle Invasive Bladder Cancer Teak Jun Shin, South Korea SP-03.47 The Peri-Meatus Location of Non-Muscle Invasive Bladder Cancer (T1): Is It a Risk Factor of Recurrence and Progression? About 274 Cases Sataa Sallami, Tunisia All SIU 2020 abstracts may be viewed via SIU Academy. 6/56 SIU 2020 Abstract Listing Last Updated: October 09, 2020 SP-03.48 Trends of Neobladder Formation in Australia Elena Galiabovitch, Australia SP-03.49 Urine Cytology: Why Don't Requesting Clinicians Follow Guidelines? Jake Tempo, Australia SP-03.50 Value of Using T2-Weighted 3-Tesla Magnetic Resonance Imaging in the Diagnosis of Localized Bladder Cancer Prior to Radical Cystectomy: Preliminary